Bioxyne (Australia) Insiders

Bioxyne Management Team Effectiveness

The company has return on total asset (ROA) of 0.2426 % which means that it generated a profit of $0.2426 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 61.2077 %, meaning that it generated $61.2077 on every $100 dollars invested by stockholders. Bioxyne's management efficiency ratios could be used to measure how well Bioxyne manages its routine affairs as well as how well it operates its assets and liabilities. Total Current Liabilities is likely to gain to about 10.2 M in 2026. Liabilities And Stockholders Equity is likely to gain to about 25.2 M in 2026Common Stock Shares Outstanding is likely to gain to about 2.6 B in 2026. Net Income Applicable To Common Shares is likely to gain to about 4.6 M in 2026Bioxyne holds a total of 2.24 Billion outstanding shares. Bioxyne retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Bioxyne Workforce Comparison

The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09.

Bioxyne Benchmark Summation

Bioxyne Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Bioxyne often depends on how effective the management is. Bioxyne management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bioxyne management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bioxyne management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Bioxyne's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bioxyne. Check Bioxyne's Beneish M Score to see the likelihood of Bioxyne's management manipulating its earnings.

When running Bioxyne's price analysis, check to measure Bioxyne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioxyne is operating at the current time. Most of Bioxyne's value examination focuses on studying past and present price action to predict the probability of Bioxyne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioxyne's price. Additionally, you may evaluate how the addition of Bioxyne to your portfolios can decrease your overall portfolio volatility.